Clinical Trial Update: Keeping RAASi Treatment With Optimal Potassium Control [Phase 3]

View source ↗

Summary

Phase 3 clinical trial recruiting to evaluate maintaining RAAS inhibitors with potassium control in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Chronic Kidney Diseases | Phase 3 | Status: RECRUITING